Home E-Weekly September 12, 2017

Disappointing Results for Laparoscopic Anti-GERD Surgery

Published: September 11, 2017

UPSETTING RESULT Women were especially vulnerable to recurrent symptoms after laparoscopic anti-reflux surgery.

Laparoscopic anti-reflux surgery failed to produce the desired results in about 1 in 6 patients, a new large-scale study has found.

The retrospective study, which was published in the Journal of the American Medical Association, found that among 2,655 adult patients who had anti-reflux surgery in Sweden between 2005 and 2014, about 18% continued to use anti-GERD medication (proton pump inhibitors or histamine H2-receptor antagonists) for more than 6 months after surgery (84%) or had secondary anti-reflux surgeries (16%).

The study didn't distinguish between patients who'd undergone total or partial fundoplication, or some other anti-reflux procedure.

Women were more likely to be vulnerable to continued GERD symptoms after surgery (22% vs. 14% of men), and older age and comorbidities were also risk factors.

The "relatively high rate of recurrent GERD requiring long-term treatment, diminish[es] some of the benefits of the operation," the authors write.

Jim Burger

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

GERD Treatments Move Forward, But Will You Get Paid?

The new CPT code is here, but you may have to battle with payers.

5 New Technologies for Treating GERD

The list of minimally invasive surgical and endoscopic options is expanding.

Special Report From DDW: 7 Cool New Gadgets Your GI Docs Will Love

A gastroenterologist tours Digestive Disease Week's exhibit hall.